![](https://investorshub.advfn.com/uicon/239211.png?cb=1524661155)
Thursday, April 03, 2014 12:43:15 AM
here is a link which strongly insinuated DR von Hoff would be on board or involved with nvlx ...this was published in febuary 19th........http://finance.yahoo.com/news/nuvilexs-pancreatic-cancer-treatment-readies-140000330.html;_ylt=A0LEV0eR3DxTWxMAvVpXNyoA;_ylu=X3oDMTEzajdlZXUzBHNlYwNzcgRwb3MDMwRjb2xvA2JmMQR2dGlkA1ZJUDM5M18x
if you were a pessimist on this stock you could read the paragraphs as a HYPE insinuation and misleading..... which end in one paragraph on how dr. hoff was instrumental in abraxanes approval for celgene......
and then started the next paragraph with....Now its nuvilex's turn......
I took the optimistic side since i am, and was back then too.long and fully invested...that optimistic side was to read into the paragraph that this was a clue that VON HOFF was already on board......or obviously would be on board soon since we are simply using the same drugs but a different/hopefully better delivery method.................and when all you have to do is just hire von hoffs cro team to do the clinical trials,.....its not that far of a stretch to Assume that this will play out the way it did......like i said in my last post.......when you play chess,you think 2 or 3 moves ahead...........I remember this message board debating if he was already in or not and HOPING he would be with that insinuation.....I took it as a given.
Im glad to see the stock react well to the anouncement.I thought it was already priced in.....maybe it wasnt...I'll take any upside we can get.
I already did some homework besides bulls remarks towards my "laziness" when i am simply "asking" his opinion of how they might price this delivery service.Dude, you might want to get off your high horse once in a while, just saying.
some 45 thousand people in the usa will be diagnosed with pancreatic cancer this year<in the usa>........so to see some serious revenues for "cell in a box".......you would have to charge at least 1000 dollars per delivery system...aside from the drug dose we probably need to buy from celgene.........just to see 45 million in REVENUE.............can we charge 10k for it?? possible....I'd pay 10k to live 6 months longer........but will they charge that much?...that would get us to 450 million a year in revenue if every single person with this disease is fast enough to get signed up with nvlx before they actually die from this fast moving killer................yes these are just the numbers in the usa but its in the usa where 1 in 4 get cancer.......in most asian countries they simply dont get this high rate of cancer....and in china they will die of this before ever getting diagnosed for it,,,....same in india,,,,dont expect many indians dishing out big bucks to cure their cancer,,let alone getting treated for it at 10k a pop.........
I am long........but these guys expecting 30 dollars a share in 5 years are NUTS..................if we could attack every cancer out there.....the websites say 1.6 million people per year<in the usa> get diagnosed with all types of cancer....then we could get those revenues up.......but every cancer needs a different treatment, that would take a decade............yes people do pay high costs for Kemo/CHEMO therapy...so maybe nvlx could get a big price tag on it.....if its just 500 bucks for this delivery system i would be shocked if we get anywhere close to a dollar a share.....as it will take years to generate the revenues and profits to justify a billion dollar market cap.
Thats why i would like to know how or what range we would charge for this delivery system to see if it would add up...........maybe i am understating the willingness of paying a much higher cost for this..........they did charge my uncle about a million dollars for his heart transplant so maybe I'm understating what we could get per procedure for this.
Not all new tech is profitable for business and i simply would like some rough estimates to use for variables.....
to include higher numbers of pancreatic patients willing to do this you would need large numbers outside the usa with doctors who know and are willing to do this procedure.that would take years of training.......Its just not as awesome as the profit making ability that big pharma has when they simply ship out their pills worldwide via ups or fedex.or will it? they would have to go to a clinic to get this treatment as it "cell in a box" needs to be in a controlled environment, and possibly administered by at least a professional nurse.
Dont attack me folks....I'd like to see cancer cured too.....but the profit potential for nvlx and the scope of it is still in question.
Please dont attack me with rude statements and remarks for voicing my concerns ..........Its easy to name call and I would prefer to see adult minded responses on this board.
I just dont know if i will be selling at 80 cents or 5.80......the variables i am searching for will be needed to make that educated decision.
here is another link in which the last paragraph also makes reference to von hoff and nvlx soon after to lead you on to the fact that something is going on there....and that there is a link between the two working together in the near future....
http://www.stockmarketmediagroup.com/move-over-celgene-here-comes-nuvilex-and-27-million-to-advance-its-pancreatic-cancer-clinical-trials/
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM